John Markels

SGMO

John Markels serves as Director at Sangamo Therapeutics, Inc. (SGMO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$25.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$25.0K

Companies Traded

SGMO

Active Period

Jun 2022

1 total trades

Most Recent

Buy SGMO

Jun 6, 2022 · $25.0K

John Markels's Insider Trading at Sangamo Therapeutics, Inc. (SGMO)

Buys

1 · $25.0K

Sells

0 · $0.00

Total Shares Bought

6,784

Total Shares Sold

SGMO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 6, 2022	Buy	6,784	$3.69	$25.0K	32,484

Related Insiders

Gregory D Davis

officer: Head of Research & Technology

SGMOSell · Apr 23, 2026

Nathalie Dubois-Stringfellow

SVP-CHIEF DEVELOPMENT OFFICER

SGMOSell · Apr 23, 2026

Prathyusha Duraibabu

SVP, CHIEF FINANCIAL OFFICER

SGMOSell · Jan 22, 2026

Nikunj Jain

Principal Accounting Officer

SGMOSell · Jan 22, 2026

Sandy Macrae

PRESIDENT, CEO AND DIRECTOR

SGMOSell · Jan 22, 2026

Scott B. Willoughby

SVP, CHIEF LEGAL OFFICER, SECY

SGMOSell · Nov 24, 2025

Explore More Insider Trading Data

SGMO Insider Trading Activity

View all insider trades at Sangamo Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity